New progress of non-surgical treatments for hepatocellular carcinoma.
about
Selective Cytotoxicity of 1,3,4-Thiadiazolium Mesoionic Derivatives on Hepatocarcinoma Cells (HepG2)Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work reviewDNA Polymerases as targets for gene therapy of hepatocellular carcinoma.A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors.Preoperative aspartate aminotransferase-to-platelet ratio index (APRI) is a predictor on postoperative outcomes of hepatocellular carcinoma.Erlotinib for advanced hepatocellular carcinoma. A systematic review of phase II/III clinical trials.Hepatectomy combined with microwave ablation of the spleen for treatment of hepatocellular carcinoma complicated with splenomegaly: A retrospective study.Ultrasound-guided intratumoral delivery of doxorubicin from in situ forming implants in a hepatocellular carcinoma model.Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway.Abnormal expression of insulin-like growth factor-I receptor in hepatoma tissue and its inhibition to promote apoptosis of tumor cells.Tamibarotene: a new hope for therapeutic efficacy in hepatocellular carcinoma patients.IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations.
P2860
Q28548419-647CD909-9135-4246-B114-4146E264C9CEQ35037545-D242EE61-220A-4756-A04C-3C8E15B1D1EBQ35579189-23E776EF-EC77-40D7-AE6F-1460EF81AEABQ37031700-0BB0483F-366B-4BB9-BAE6-F8FAE9CA8DC9Q37467907-4539167E-27A8-4853-9397-70E5CEA38A19Q37637658-4C300088-B128-441B-A9CC-B0B8ACCA73B5Q37701809-3C91328D-22A2-4CE7-8D1E-98E961C8CEBDQ38783457-7C0630D8-8DE6-4CCD-9B06-F64BA04BB181Q38941385-89457DAD-7B5A-4630-8F80-26756D778AD0Q39135542-CFE4CFED-3D25-471B-8F09-E8EC305A15FCQ40706111-34E77CFB-05B2-4226-B1D6-6459529DC170Q45858225-3D80B390-E423-4196-9934-1FBB5786BBD8Q50224629-073E3C4B-11C8-4F9C-903B-70597E88B03F
P2860
New progress of non-surgical treatments for hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New progress of non-surgical treatments for hepatocellular carcinoma.
@ast
New progress of non-surgical treatments for hepatocellular carcinoma.
@en
New progress of non-surgical treatments for hepatocellular carcinoma.
@nl
type
label
New progress of non-surgical treatments for hepatocellular carcinoma.
@ast
New progress of non-surgical treatments for hepatocellular carcinoma.
@en
New progress of non-surgical treatments for hepatocellular carcinoma.
@nl
prefLabel
New progress of non-surgical treatments for hepatocellular carcinoma.
@ast
New progress of non-surgical treatments for hepatocellular carcinoma.
@en
New progress of non-surgical treatments for hepatocellular carcinoma.
@nl
P2860
P1433
P1476
New progress of non-surgical treatments for hepatocellular carcinoma.
@en
P2093
P2860
P2888
P356
10.1007/S12032-012-0381-Y
P577
2013-01-06T00:00:00Z
P6179
1007278784